Blood Vessels News and Research

RSS

Shock wave therapy shows remarkable results in wound healing and curing myocardial diseases

Effective, non-invasive and practically without side effects - extracorporeal shock wave therapy has demonstrated impressive results not only in orthopedics and traumatology, but also in treating fresh and chronic wounds as well as circulatory disorders of the myocardial muscle.

31 May 2005

Fluorescence device to diagnose atherosclerosis and tumors

In a presentation at the Conference on Lasers and Electro-Optics (CLEO), researchers from Cedars-Sinai Medical Center's Biophotonics Research and Technology Development Laboratory described recent progress on a device that stimulates, collects and measures light emissions from body tissues to diagnose critical atherosclerotic plaques (vulnerable plaques) and aggressive brain tumors.

29 May 2005

New study shows that bypass surgery is more successful than stents in heart surgery

A study of nearly 60,000 patients has found that people with several clogged heart arteries did better if they had bypass surgery rather than a less-drastic procedure in which the blood vessels are propped open with tiny mesh cylinders called stents.

26 May 2005

'Bad' metabolism cloggs up arteries

Scientists are now saying that a 'bad' metabolism may explain why some people who have never smoked and do not have high cholesterol levels suffer from a potentially lethal build-up of plaque in the arteries.

26 May 2005

Direct link between inefficient metabolism and atherosclerosis

An experiment that turned out very differently than expected led scientists at Washington University School of Medicine in St. Louis to the first direct link between inefficient metabolism and atherosclerosis.

26 May 2005

Study shows how COX-2 inhibitors lead to heart disease

University of Pennsylvania School of Medicine researchers have found additional evidence that may help explain how selective inhibitors of COX-2 might predispose individuals to heart disease and stroke.

26 May 2005

Female lung transplant recipients more likely to suffer from primary graft dysfunction

Female lung transplant recipients are significantly more likely to suffer from a type of injury to the transplanted lung called primary graft dysfunction than male lung transplant patients, according to a study presented at the American Thoracic Society International Conference.

25 May 2005

Cyclophosphamide may be a possible therapy for scleroderma

A drug that suppresses the immune system and reduces inflammation has been shown to be effective in treating lung disease associated with the devastating connective tissue disease scleroderma, according to results presented at the American Thoracic Society International Conference on May 23.

24 May 2005

Patients at high risk of stroke may need to continue Warfarin therapy after heart rhythm is controlled

Treatment with warfarin, a medication that prevents blood clotting, may reduce the risk of stroke by more than two-thirds in patients with atrial fibrillation (AF), a condition which places them at high risk of stroke, according to a study in the May 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

23 May 2005

Anti-inflammatory protein annexin 1 may protect patients from the detrimental effects of severe inflammatory response syndrome

Severe inflammatory response syndrome, or SIRS, occurs when the body's response to an overwhelming infection becomes uncontrolled. The very immune response meant to clear the pathogen and its toxins actually causes damage to the host's own tissues when it goes into overdrive, releasing too many immune signals.

23 May 2005

Risks outweigh benefits of shark cartilage as anti-cancer treatment

As a treatment for advanced cancer, shark cartilage fails to benefit patients and its adverse effects lead to poor compliance.

23 May 2005

Cetuximab (Erbitux) can battle cancer and prolong life in many patients with advanced colorectal cancer

"Even in people who have gone through six or more previous courses of chemotherapy, cetuximab, may fight the growth of cancer, giving patients additional months of life," says study presenter Heinz-Josef Lenz, M.D., associate professor of medicine at the Keck School of Medicine of the University of Southern California and USC/Norris Comprehensive Cancer Center.

20 May 2005

Bacteria in plaque may increase risk for heart attacks

Researchers have found evidence that the amount of bacteria in subgingival plaques, the deep plaques in periodontal pockets and around the teeth, may contribute to an individual's risk of a heart attack, according to two studies appearing the Journal of Periodontology.

20 May 2005

Two out of three Americans with type-2 diabetes do not have their disease under control

According to a new survey two out of three Americans with type-2 diabetes do not have their disease under control and are putting themselves at risk of early deaths from stroke, heart attack or kidney failure as well as blindness and limb loss.

18 May 2005

Advanced breast cancer drug appears effective on multiple targets

An experimental breast cancer drug that simultaneously attacks five tumor targets has halted progression of the disease in a clinical trial for patients with advanced disease.

18 May 2005

Tumor vasculature has become an attractive target in the treatment of cancer.

Treatment with a protein fused to an antibody in tumor-bearing mice led to coagulation of the blood within the tumor blood vessels, tumor tissue death, and tumor growth delay, according to a new study in the May 18 issue of the Journal of the National Cancer Institute.

17 May 2005

Scientists have uncovered a new method the immune system uses to label foreign invaders as targets to be attacked

Researchers showed that the immune system can brand foreign proteins by chemically modifying their structure, and that these modifications increased the chances that cells known as lymphocytes would recognize the trespassers and attack them.

17 May 2005

Engineers have found a way to modify a plastic to anchor molecules that promote nerve regeneration, blood vessel growth or other biological processes

In the study led by Dr. Christine Schmidt, the researchers identified a piece of protein from among a billion candidates that could perform the unusual feat of attaching to polypyrrole, a synthetic polymer (plastic) that conducts electricity and has shown promise in biomedical applications.

17 May 2005

SU11248 drug show promise against neuroendocrine tumors-stubborn cancers that respond poorly to chemotherapy

A unique, targeted anti-cancer drug appears to show promise against neuroendocrine tumors-stubborn cancers that have traditionally responded poorly to chemotherapy, according to research findings announced at the 2005 Annual Meeting of the American Society of Clinical Oncology (ASCO).

17 May 2005

Stents coated in polytetrafluoroethylene help keep blood vessels open for cirrhosis patients

Stents coated in polytetrafluoroethylene, the same substance used in non-stick cooking utensils, improves their ability to keep blood vessels open in TIPS procedures, decreasing occurrences of relapse and avoiding intervention, say a group of researchers led by Vina C. Williams, MD, from Leiden University Medical Center in the Netherlands.

17 May 2005

Blood Vessels News and Research

Shock wave therapy shows remarkable results in wound healing and curing myocardial diseases

Fluorescence device to diagnose atherosclerosis and tumors

New study shows that bypass surgery is more successful than stents in heart surgery

'Bad' metabolism cloggs up arteries

Direct link between inefficient metabolism and atherosclerosis

Study shows how COX-2 inhibitors lead to heart disease

Female lung transplant recipients more likely to suffer from primary graft dysfunction

Cyclophosphamide may be a possible therapy for scleroderma

Patients at high risk of stroke may need to continue Warfarin therapy after heart rhythm is controlled

Anti-inflammatory protein annexin 1 may protect patients from the detrimental effects of severe inflammatory response syndrome

Risks outweigh benefits of shark cartilage as anti-cancer treatment

Cetuximab (Erbitux) can battle cancer and prolong life in many patients with advanced colorectal cancer

Bacteria in plaque may increase risk for heart attacks

Two out of three Americans with type-2 diabetes do not have their disease under control

Advanced breast cancer drug appears effective on multiple targets

Tumor vasculature has become an attractive target in the treatment of cancer.

Scientists have uncovered a new method the immune system uses to label foreign invaders as targets to be attacked

Engineers have found a way to modify a plastic to anchor molecules that promote nerve regeneration, blood vessel growth or other biological processes

SU11248 drug show promise against neuroendocrine tumors-stubborn cancers that respond poorly to chemotherapy

Stents coated in polytetrafluoroethylene help keep blood vessels open for cirrhosis patients

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News